Centrally acting peptides and tolerance to ethanol

Area of Science:

• Neuroscience
• Pharmacology
• Endocrinology

Background:

• Ethanol tolerance, dependence, and withdrawal are complex processes.
• Neurohypophyseal hormones, like arginine vasopressin (AVP), are implicated in modulating ethanol's effects.
• Previous research suggests these peptides influence learning and memory.

Purpose of the Study:

• To investigate the role of arginine vasopressin (AVP) and related peptides in ethanol tolerance and dependence.
• To explore the differential effects of AVP on ethanol tolerance versus memory processes.
• To examine the influence of neuropeptides on initial ethanol sensitivity and consumption.

Main Methods:

• Administration of exogenous AVP and its analogs in animal models.
• Assessment of ethanol tolerance, withdrawal symptomatology, and initial sensitivity.
• Structure-activity relationship analyses for AVP and related peptides.
• Investigation of neuropeptide modulation of ethanol intake.

Main Results:

• Exogenous AVP administration maintained established ethanol tolerance.
• AVP analogs facilitated ethanol tolerance development and worsened withdrawal symptoms.
• Structural requirements for AVP's effects on ethanol tolerance differ from those for memory facilitation.
• Thyrotropin-releasing hormone (TRH) antagonized initial ethanol responses, while AVP potentiated sedation.
• Neurohypophyseal peptides were shown to modulate ethanol intake.

Conclusions:

• Arginine vasopressin (AVP) plays a significant role in the neurobiological adaptations underlying ethanol tolerance and dependence.
• Distinct neurobiological mechanisms may underlie AVP's effects on ethanol tolerance and memory.
• Neuropeptides, including AVP and TRH, act as endogenous modulators of ethanol's acute effects, withdrawal, and consumption patterns.